Beta Bionics, Inc. (BBNX) Reports Q4 Loss of $2.72

Beta Bionics, Inc. (NASDAQ: BBNX) reported Q4 EPS of ($2.72). Revenue for the quarter came in at $20.44 million.

For earnings history and earnings-related data on Beta Bionics, Inc. (BBNX) click here.

You May Also Be Interested In

• UBS Upgrades Smoore International Holdings Limited (6969:HK) (SMORF) to Buy
• Macquarie Downgrades Tongcheng Travel Holdings Ltd (780:HK) to Neutral
• RBC Capital Downgrades ARB Corp Ltd (ARB:AU) to Sector Perform